| abstract |
A compound of formula I or a pharmaceutically acceptable salt thereof, is capable of modulating the body's production of cyclic guanosine monophosphate (cGMP) and is generally suitable for the therapy and prophylaxis of diseases that are associated with a disturbed balance of cGMP. . The invention further relates to processes for preparing compounds of formula I or a pharmaceutically acceptable salt thereof, for their use in the therapy and prophylaxis of the above-mentioned diseases and for the preparation of pharmaceutical products intended for this purpose, and to pharmaceutical preparations comprising compounds of Formula I or a pharmaceutically acceptable salt thereof. |